ARCHIVES

NIH Should Review CRADA Pricing, Wyden Write to Shalala

This article is from The Cancer Letter archive.

Vol. 19 No. 06 | February 5, 1993

Download PDF Visit The Full Archive

Related Articles

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

University of Oklahoma Wins Planning Grant; Three Mile Island Follow-Up Finds No Significant Increase In Cancer Deaths

November 2, 2002

New Cooperative Group Funded

September 30, 1977

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

April 16, 2004

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989